Publications by authors named "Alexandre Fourcade"

Claim this Profile
I
Incidence of Significant Prostate Cancer in the Follow-Up of Patients With Suspicious Lesion on MRI and Negative Targeted and systematic Biopsies.
Claire Siebert, Truong-An Nguyen, Alexandre Fourcade, Audrey Zambon, Kevin Saout

Clin Genitourin Cancer· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Refining clinically relevant cut-offs of prostate specific antigen density for risk stratification in patients with PI-RADS 3 lesions.
Georges Mjaess, Laura Haddad, Teddy Jabbour, Arthur Baudewyns, Henri-Alexandre Bourgeno, Alexandre Fourcade

Prostate Cancer Prostatic Dis· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Added Value of Side-specific Systematic Biopsy in Patients Diagnosed by Magnetic Resonance Imaging-targeted Prostate Biopsy.
Henri-Alexandre Bourgeno, Teddy Jabbour, Arthur Baudewyns, Yolène Lefebvre, Mariaconsiglia Ferriero, Alexandre Fourcade

Eur Urol Oncol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does Overgrading on Targeted Biopsy of Magnetic Resonance Imaging-visible Lesions in Prostate Cancer Lead to Overtreatment?
Michael Baboudjian, Romain Diamand, Alessandro Uleri, Jean-Baptiste Beauval, Alae Touzani, Alexandre Fourcade

Eur Urol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transperineal or Transrectal Magnetic Resonance Imaging-targeted Biopsy for Prostate Cancer Detection.
Romain Diamand, Karsten Guenzel, Georges Mjaess, Yolène Lefebvre, Mariaconsiglia Ferriero, Alexandre Fourcade

Eur Urol Focus· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transrectal versus transperineal prostate fusion biopsy: a pair-matched analysis to evaluate accuracy and complications.
Marco Oderda, Romain Diamand, Rawad Abou Zahr, Julien Anract, Gregoire Assenmacher, Alexandre Fourcade

World J Urol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MRI lesion size is more important than the number of positive biopsy cores in predicting adverse features and recurrence after radical prostatectomy: implications for active surveillance criteria in intermediate-risk patients.
Michael Baboudjian, Alessandro Uleri, Jean-Baptiste Beauval, Alae Touzani, Romain Diamand, Alexandre Fourcade

Prostate Cancer Prostatic Dis· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
External validation and comparison of magnetic resonance imaging-based risk prediction models for prostate biopsy stratification.
Romain Diamand, Karsten Guenzel, Teddy Jabbour, Arthur Baudewyns, Henri-Alexandre Bourgeno, Alexandre Fourcade

World J Urol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of prostate volume estimation on the risk-adapted biopsy decision based on prostate-specific antigen density and magnetic resonance imaging score.
Arthur Baudewyns, Karsten Guenzel, Adam Halinski, Charles Dariane, Gina Delavar, Alexandre Fourcade

World J Urol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting contralateral extraprostatic extension in unilateral high-risk prostate cancer: a multicentric external validation study.
Romain Diamand, Jean-Baptiste Roche, Vito Lacetera, Giuseppe Simone, Olivier Windisch, Alexandre Fourcade

World J Urol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Novel Nomogram to Identify Candidates for Focal Therapy Among Patients with Localized Prostate Cancer Diagnosed via Magnetic Resonance Imaging-Targeted and Systematic Biopsies: A European Multicenter Study.
Georges Mjaess, Alexandre Peltier, Jean-Baptiste Roche, Elena Lievore, Vito Lacetera, Alexandre Fourcade

Eur Urol Focus· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Magnetic Resonance Imaging-based T-staging to Predict Biochemical Recurrence after Radical Prostatectomy: A Step Towards the iTNM Classification.
Michael Baboudjian, Bastien Gondran-Tellier, Alae Touzani, Alberto Martini, Romain Diamand, Alexandre Fourcade

Eur Urol Oncol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimal PSA density threshold and predictive factors for the detection of clinically significant prostate cancer in patient with a PI-RADS 3 lesion on MRI.
Truong-An Nguyen, Alexandre Fourcade, Audrey Zambon, Kevin Saout, Charles Deruelle

Urol Oncol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk stratification for early biochemical recurrence of prostate cancer in the era of multiparametric magnetic resonance imagining-targeted biopsy.
Romain Diamand, Alexandre Peltier, Jean-Baptiste Roche, Elena Lievore, Vito Lacetera, Alexandre Fourcade

Prostate· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expanding inclusion criteria for active surveillance in intermediate-risk prostate cancer: a machine learning approach.
Michael Baboudjian, Alberto Breda, Thierry Roumeguère, Alessandro Uleri, Jean-Baptiste Roche, Alexandre Fourcade

World J Urol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of age on the Quadrella index assessing oncological and functional results after prostate brachytherapy: A 6-year analysis.
Guillaume Tremblay, Truong An Nguyen, Julien Marolleau, Jean-Pierre Malhaire, Alexandre Fourcade

J Contemp Brachytherapy· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
External Validation of Models for Prediction of Side-specific Extracapsular Extension in Prostate Cancer Patients Undergoing Radical Prostatectomy.
Romain Diamand, Jean-Baptiste Roche, Elena Lievore, Vito Lacetera, Giuseppe Chiacchio, Alexandre Fourcade

Eur Urol Focus· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expanding Active Surveillance Criteria for Low- and Intermediate-risk Prostate Cancer: Can We Accurately Predict the Risk of Misclassification for Patients Diagnosed by Multiparametric Magnetic Resonance Imaging-targeted Biopsy?
Romain Diamand, Simone Albisinni, Jean-Baptiste Roche, Elena Lievore, Vito Lacetera, Alexandre Fourcade

Eur Urol Focus· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oncological outcomes of radical prostatectomy in very high-risk patients according to STAMPEDE criteria: does local treatment alone still have a place in the era of intensified systemic therapies?
Michael Baboudjian, Alae Touzani, Alberto Martini, Romain Diamand, Jean B Roche, Alexandre Fourcade

Minerva Urol Nephrol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimizing multiparametric magnetic resonance imaging-targeted biopsy and prostate cancer grading accuracy.
Romain Diamand, Alexandre Peltier, Jean-Baptiste Roche, Elena Lievore, Vito Lacetera, Alexandre Fourcade

World J Urol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Multiparametric MRI and PSA Density on the Initial Indication or the Maintaining in Active Surveillance During Follow-Up in low-Risk Prostate Cancer.
Kevin Saout, Audrey Zambon, Truong An Nguyen, Caroline Lucas, Charlotte Payrard-Starck, Alexandre Fourcade

Clin Genitourin Cancer· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stratifying patients with intermediate-risk prostate cancer: Validation of a new model based on MRI parameters and targeted biopsy and comparison with NCCN and AUA subclassifications.
Romain Diamand, Guillaume Ploussard, Mathieu Roumiguié, Bernard Malavaud, Marco Oderda, Alexandre Fourcade

Urol Oncol· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
External validation of the Briganti nomogram predicting lymph node invasion in patients with intermediate and high-risk prostate cancer diagnosed with magnetic resonance imaging-targeted and systematic biopsies: A European multicenter study.
Romain Diamand, Marco Oderda, Simone Albisinni, Alexandre Fourcade, Georges Fournier

Urol Oncol· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective four years of evaluation of erectile function after low-dose-rate prostate brachytherapy using baseline IIEF-5 > 16.
Nadja Schoentgen, Julien Marolleau, Francky Delage, Jean-Baptiste Coquet, Alexandre Fourcade

J Contemp Brachytherapy· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the "Quadrella" at 3 years: New index to assess functional and oncological performance specific to prostate brachytherapy.
Jean-Baptiste Coquet, Francky Delage, Alexandre Fourcade, Pierre Callerot, Gaelle Goasduff

Brachytherapy· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis